AzTrials
AzTrials

Children Under General AnaesthesiaTABLETNCT03531359

Tablet-based Interactive Distraction Preoperative Anxiety in Children: A Randomized Controlled Trial

A study testing TIBD and Midazolam in people with Children Under General Anaesthesia, run by Universidad de Valparaiso at 1 site in Chile.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Children develop anxiety during the induction of anaesthesia and video-games might reduce or alleviate it. The investigators intend to conduct a clinical trial to study the effect of tablet-based interctive games on alleviating preoperative anxiety. Read more about this study

Who is it for?
Ages 2 to 10 years
Conditions the study is for
Children Under General Anaesthesia
What is being tested?
TIBD and Midazolam
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteChile
Study dates
4 Jul 2018to 30 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 2-10 years, under major surgery ambulatory program at Hospital Carlos Van Buren, with no contraindication for the use of midazolam.

Who cannot join

  • Patients with cognitive impairment or sensory deficit Patients with previous history of major surgery will also be excluded Patients with myastenia "Hard airway" History of paroxystic reaction to benzodiazepines Attentional deficit hyperactivity disorder Sleep aphnea Full stomach Adenotonsillar hypertrophy Respiratory acute infections

Trial locations and contacts

1 site in 1 country.

Nathalie López, MD contact

2364000

nathalielopez.jq@gmail.com

Anamaria Correa, MD contact

2364000

anamaria.correa@uv.cl

Chile1 site, 1 recruiting
  • Hospital Carlos Van Buren

    Valparaíso, 2341131

    Nathalie Lopez, M.D., 2364000, nathalielopez.jq@gmail.com

    Anamaria Correa, M.D., correanamaria@gmail.com

    Recruiting

Other trials in Chile

About this study

Official title: Tablet-based Interactive Distraction for the Management of Preoperative Anxiety in Children: A Randomized Controlled Trial

Children develop anxiety during the induction of anaesthesia and video-games might reduce or alleviate it. The investigators intend to conduct a clinical trial to study the effect of tablet-based interctive games on alleviating preoperative anxiety.

Read the detailed description

It is estimated that 50% of children may suffer preoperative anxiety. They have a higher risk of generating postanesthetic delirium and behavioral changes in the postoperative period up to 67% of cases.

For the management of preoperative anxiety there are pharmacological and non-pharmacological treatments. Within the first group there's the use of benzodiazepines of short half life like midazolam, however, the use of this medication is not exempt of risks such as paradox reactions, respiratory depression, among others. This is why the non pharmacological mesures have taken force and every day there is more evidence regarding its effectiveness.

There are no reports in Chile or latin america regarding the use of this tools, this is why the investigators designed this study to prove the effectiveness of audiovisual distraction measures in reducing preparatory anxiety compared to premeditation with midazolam.

Being tested
TIBD, Midazolam

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TIBDDevice

    Table-based Interactive Distraction using video-games will be used to prove efficacy in preventing preoperative anxiety.

  • MidazolamDrug

    Administration of midazolam oral or rectal 30 minutes to one hour prior to transfer to the theater.

Study groups in NCT03531359
Study groupRoleWhat they receive
TIBD Tablet-based video distractionExperimentalChildren will receive of tablet-based interctive games in preoperatory room
Receives: Device: TIBD
MidazolamActive comparatorChildren will be premedicated with usual treatmente (midazolam)
Receives: Drug: Midazolam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Short version of the modified Yale Preoperative Anxiety Scale(mYPAS-SF)

    Difference between the measurement of the mYPAS-SF applied in the preoperative time and prior to induction.

    The scale has 18 items in 4 categories. Maximum score is 100 points. The higher the score, the greater the anxiety.

    Measured: 6 hours

Secondary outcomes (4)
  1. Cooperation with the induction

    Scale with 10 items, 1 point for each one. 0 points shows an induction with perfect cooperation.

    This scale will be applied at the moment of the induction by the anesthesiologist

    Measured: 30 minuts

  2. Changes in postoperative behavior

    The Post Behavioral Behavior Change Questionnaire (PHBQ) will be applied at the postoperative surgical control (7-10 days after the intervention). This survey will be applied by people trained by the hospital's pediatric psychiatry team The higher the score, the more behavioral changes in the postoperative period

    Measured: 10 days

  3. Emergence delirium

    In the post-anesthesia recovery unit, the Emergency Delirium Scale for Pediatric Anesthesia (PAED) will be applied every 15 minutes during the first 30 minutes of their stay in the unit. Score goes from 0 to 20. Scores greater than 10 is considered as delirium.

    Measured: 1 hour

  4. Parents Satisfaction

    A gradual scale will be applied to the parents of the patient upon discharge from hospital.

    Measured: 10 minuts

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2018
  2. Study start4 Jul 2018
  3. Primary completion30 Jun 2019 (estimated)
  4. Study completion30 Jul 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Tablet Group: They'll receive a tablet with content adapted to every group. It will be divided into 4 groups (2-4 years, 4-6 years, 6-8 years and 9-10 years). The first one will receive cartoons, the second will also have games; for the other two groups will be assigned appropriate video games depending on the age. Midazolam group: They'll receive 0,5mg/kg oral or it's equivalent in rectal administration 30 minutes to one hour prior to transfer to the theater. This patients will not be able to have contact with audiovisual devices.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
112 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03531359
Sponsor's protocol ID
UV-1-2018
Acronym
TABLET
Status last verified
Sep 2018
First submitted
30 Apr 2018
Last updated
5 Sep 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing TIBD and Midazolam in people with Children Under General Anaesthesia, run by Universidad de Valparaiso at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Nathalie López, MD (2364000, nathalielopez.jq@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Short version of the modified Yale Preoperative Anxiety Scale(mYPAS-SF) (time frame: 6 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in